We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CZR
2151
DELISTED
Caesars Entertainment Corporation
CZR
| $634K | ﹤0.01% |
66,410
+2,667
| +4% | +$24.4K |
|
2152
SiteOne Landscape Supply
SITE
$4.12B
| $631K | ﹤0.01% |
13,037
+1,197
| +10% | +$47.8K |
|
|
TSC
2153
DELISTED
TriState Capital Holdings, Inc.
TSC
| $626K | ﹤0.01% |
26,817
+1,858
| +7% | +$42.5K |
|
|
AAMI
2154
Acadian Asset Management
AAMI
$3.08B
| $625K | ﹤0.01% |
41,307
+1,730
| +4% | +$25.5K |
|
2155
Powell Industries
POWL
$7.6B
| $622K | ﹤0.01% |
54,201
+13,827
| +34% | +$164K |
|
2156
Vanda Pharmaceuticals
VNDA
$307M
| $622K | ﹤0.01% |
44,422
+1,550
| +4% | +$22.1K |
|
2157
Teladoc Health
TDOC
$1.22B
| $620K | ﹤0.01% |
24,810
+3,653
| +17% | +$76K |
|
|
MITT
2158
TPG Mortgage Investment Trust
MITT
$222M
| $618K | ﹤0.01% |
11,414
+362
| +3% | +$19.1K |
|
|
GNMK
2159
DELISTED
GenMark Diagnostics, Inc
GNMK
| $616K | ﹤0.01% |
48,037
+2,321
| +5% | +$27.9K |
|
|
AHRT
2160
AH Realty Trust
AHRT
$529M
| $614K | ﹤0.01% |
44,170
+5,526
| +14% | +$77K |
|
2161
Peoples Bancorp
PEBO
$1.5B
| $614K | ﹤0.01% |
19,389
+1,357
| +8% | +$43.4K |
|
|
TBRG
2162
DELISTED
TruBridge
TBRG
| $613K | ﹤0.01% |
21,901
-13,927
| -39% | -$349K |
|
|
CSW
2163
CSW Industrials
CSW
$5.2B
| $612K | ﹤0.01% |
16,686
+489
| +3% | +$17.9K |
|
|
KERX
2164
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $612K | ﹤0.01% |
99,376
+6,750
| +7% | +$37K |
|
|
LUMO
2165
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $609K | ﹤0.01% |
2,808
+91
| +3% | +$13K |
|
|
OKSB
2166
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $608K | ﹤0.01% |
23,255
+812
| +4% | +$22.3K |
|
|
NSM
2167
DELISTED
Nationstar Mortgage Holdings
NSM
| $606K | ﹤0.01% |
38,446
+1,096
| +3% | +$19.4K |
|
|
NXRT
2168
NexPoint Residential Trust
NXRT
$666M
| $604K | ﹤0.01% |
24,983
+1,929
| +8% | +$45.1K |
|
2169
Match Group
MTCH
$9.19B
| $603K | ﹤0.01% |
36,941
+2,335
| +7% | +$39.9K |
|
|
KE
2170
Kimball Electronics
KE
$595M
| $602K | ﹤0.01% |
35,523
+938
| +3% | +$15.6K |
|
2171
Horizon Bancorp
HBNC
$1.04B
| $601K | ﹤0.01% |
34,406
+1,230
| +4% | +$21.4K |
|
|
CTT
2172
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $597K | ﹤0.01% |
51,842
+3,654
| +8% | +$39.6K |
|
|
ACHN
2173
DELISTED
Achillion Pharmaceuticals
ACHN
| $597K | ﹤0.01% |
141,759
+10,174
| +8% | +$42.2K |
|
|
KMG
2174
DELISTED
KMG Chemicals Inc
KMG
| $597K | ﹤0.01% |
12,948
+1,273
| +11% | +$49.7K |
|
|
UAM
2175
DELISTED
Universal American Corp
UAM
| $597K | ﹤0.01% |
59,866
+1,266
| +2% | +$12.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.